Multi-event September 2025 FDA Recall Sulfamethoxazole And Trimethoprim by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

This Multi-event Class II drug recall was voluntarily initiated by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories on September 2, 2025 for the product Sulfamethoxazole And Trimethoprim. The FDA reported the reason for recall as presence of a foreign substance. The product was distributed Nationwide and the recall is currently ongoing.

Reported Recall Events

Recall Number: D-0624-2025

Reason for Recall
Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Initiated
09-02-2025
Reported
09-17-2025
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packs (10x10) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-2725-61

Batch or Lot Expiration Information

Lot# N02309, Exp 03/31/2027

Affected Packages Involved in this Recall

Recall Number: D-0625-2025

Reason for Recall
Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Initiated
09-02-2025
Reported
09-17-2025
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1) per bag, Rx only, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-7895-0 (Outer Bag) containing NDC 0904-2725-61 (Inner blisters).

Batch or Lot Expiration Information

Lot# Bag: N02309A and N02309B, Exp Date: 03/31/2027; Inner blister:
Lot# N02309, Exp Date: 03/31/2027